Shubham Rathi

Shubham Rathi

Director DIN 07901882
DIN 07901882 First appointment Aug 2017
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Shubham Rathi

Data last updated:

Shubham Rathi was a Director at Ryzil Pharmaceuticals Private Limited (from 2017) and Managing Director at Sixten28 Ryzil Private Limited (from 2018).

DIN 07901882
First Appointment 18 Aug 2017
Oldest Company Age 9 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Aug 20172017₹5.3 Lakh (FY 2018)Strike Off
Sixten28 Ryzil Private Limited U70109UP2018PTC111307
Managing Director17 Dec 20182018Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ryzil Pharmaceuticals Private Limited
Sixten28 Ryzil Private Limited
Premium access

Shareholding and investment profile for Shubham Rathi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shubham Rathi

Shubham Rathi was first appointed on 18 Aug 2017 as Director at Ryzil Pharmaceuticals Private Limited. The most recent appointment on record is 17 Dec 2018 at Sixten28 Ryzil Private Limited.

Shubham Rathi held 2 earlier board appointments: Ryzil Pharmaceuticals Private Limited (Director, from 18 Aug 2017); Sixten28 Ryzil Private Limited (Managing Director, from 17 Dec 2018).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available